https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Liquid Embolics

Showing all 4 results

Neurological Devices Market Size, Share & COVID-19 Impact Analysis | United States | 2022-2028 | MedSuite | Includes: Neurovascular Catheters, Neuromodulation Devices, and 12 more

iData’s U.S. neurology devices market MedSuite covers 14 markets and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

more...

Neurological Devices Market Size, Share & COVID-19 Analysis | Europe | 2023-2029 | MedSuite | Includes: Ultrasonic Aspirator Market, Neurovascular Guidewires Market, and 12 more

The full report suite on the European market for neurological devices includes cerebrospinal fluid management devices, detachable coils, liquid embolics, neurovascular guidewires, neurovascular catheters, neurovascular stents, aneurysm clips, balloon occlusion devices, neurovascular thrombectomy devices, ultrasonic aspirators, neuromodulation devices, intrathecal pumps, stereotactic devices and transcranial magnetic simulators.

more...

Neurological Devices Market Size, Share & Trends Analysis | Global | 2019-2025 | MedSuite | Includes: Detachable Coils Market, Neurovascular Stents Market, and 13 more

iData’s global neurology devices market MedSuite covers 15 markets including procedure numbers and COVID-19 impacts. The MedSuite is a compilation of all reports related to a specific market. It is ideal for device manufacturers, product managers, marketing managers, and consultants looking for a detailed analysis of every market segment and sub-segment within a given market.

more...

Liquid Embolics Market Analysis | United States | 2020-2026 | MedCore

Liquid embolics currently on the market include N-butyl cyanoacrylate (NBCA) (TRUFILL®) and an ethylene-vinyl alcohol copolymer (Onyx®). These agents are injected through microcatheters and act like glue in abnormal blood vessels. When they contact blood they solidify and obstruct the vessel lumen therefore blocking the flow of blood through malformed blood vessels and reducing the risk of rupture. The surgeon performing the procedure must flush the catheter before and after injecting the NBCA to prevent the liquid agent from sticking to the catheter. Thus this procedure requires a highly skilled physician. This is often done prior to the removal of these vessels in order to simplify the surgical procedure.

more...